JBIO Jade Biosciences, Inc.
Healthcare$21.71-2.25%ClosedMarket Cap: $708.3M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
4.33
P/S
0.00
EV/EBITDA
-5.02
DCF Value
$2.74
FCF Yield
-16.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-51.3%
ROA
-40.6%
ROIC
-45.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-43.4M | $-40.4M | $— | — |
| Q4 null | $0.00 | NaN% | $-35.0M | $-31.9M | $— | — |
| FY null | $0.00 | NaN% | $-113.5M | $-127.4M | $— | $2.40 |
| Q3 null | $0.00 | NaN% | $-27.4M | $-25.2M | $— | — |
| Q2 null | $0.00 | NaN% | $-27.8M | $-32.1M | $— | $2.40 |
| Q1 null | $0.00 | -Infinity% | $-3.4M | $-2.5M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-6.4M | $-5.4M | $— | — |
| FY null | $0.00 | -Infinity% | $-74.6M | $-69.6M | $— | — |
| Q3 null | $0.00 | NaN% | $-15.0M | $-16.3M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-26.2M | $-24.8M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-24.6M | $-23.2M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-22.1M | $-20.4M | $-25.80 | — |